THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK - THIS TASK ORDER IS TO CONDUCT THE TESTING OF CANDIDATE ANTIVIRAL THERAPIES AGAINST VZV OR HCMV IN HUMAN SKIN XENOGRAFT MOUSE MODELS AND SKIN ORGAN CULTURES IN NON-GOOD LABORATORY PRACTICE (GLP) CONDITIONS.
Key Details
Description
THIS TASK ORDER IS TO CONDUCT THE TESTING OF CANDIDATE ANTIVIRAL THERAPIES AGAINST VZV OR HCMV IN HUMAN SKIN XENOGRAFT MOUSE MODELS AND SKIN ORGAN CULTURES IN NON-GOOD LABORATORY PRACTICE (GLP) CONDITIONS.
Context & Analysis
On Dec 3, 2025, Department of Health and Human Services obligated $480,856 to THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK for this task order is to conduct the testing of candidate antiviral therapies against vzv or hcmv in human skin xenograft mouse models and skin organ cultures in non-good laboratory practice (glp) condit…. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in SYRACUSE, NY. The contract is scheduled through Dec 7, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.